Baxter Stock Price Projections For 2024. (bax) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $42.42, representing a +20.62% increase from the current price of $35.17. (nyse:bax), a global medtech leader, today reported results for the fourth quarter and full year ended.
The zacks consensus estimate has increased $0.01 to $2.90 per share. Zacks research also issued estimates for baxter international’s q3.
We Arrive At A Consolidated Target Price Of $48.00 Per Share For Baxter International Inc., Which Implies A Potential Upside Of 21.1% From The Current Market.
Zacks research also issued estimates for baxter international's q3.
(Nyse:bax), A Global Medtech Leader, Will Present At The Jefferies 2024 Global Healthcare Conference.
Adjusted close price adjusted for splits and dividend and/or capital gain.
(Bax) Stock Price Forecast For The Next 30 Days Is Generally Positive, With An Average Analyst Price Target Of $42.42, Representing A +20.62% Increase From The Current Price Of $35.17.
Images References :
For Fiscal 2024, Five Analysts Revised Their Earnings Estimate Higher In The Last 60 Days For Bax, While The Zacks Consensus Estimate Has Increased $0.01 To $2.90 Per.
The zacks consensus estimate has increased $0.01 to $2.90 per share.
(Nyse:bax), A Global Medtech Leader, Will Present At The Jefferies 2024 Global Healthcare Conference On Wednesday, June 5, 2024.
Baxter “modestly raised guidance” for 2023, “likely to reflect 1q outperformance, while still maintaining forward conservatism,” analysts with keybanc.